4Tissue
Benoit Moreaux currently serves as Head of Operations at AbolerIS Pharma and is a Board Member at THYMOLUX. In addition, Benoit Moreaux holds the position of VP Drug Development at 2 Bridge and Chairman of the Board at CER Groupe. Previously, Benoit Moreaux was the Chief Executive Officer at 4Tissue Laboratory and General Manager at Quality by Design, as well as COO at Bio-Sourcing. Benoit Moreaux has experience as Chief Scientific and Technological Officer at BONE THERAPEUTICS S.A., and has held multiple senior roles at Nikkiso, including Chief Scientific Officer and Managing Director, where significant achievements included founding Nikkiso Belgium and obtaining multiple certifications. Benoit Moreaux began the professional career at Baxter International Inc. as a Senior Project Manager. Academically, Benoit Moreaux holds a PhD from the University of Liège and has been a certified Project Management Professional since 2009.
This person is not in any teams
This person is not in any offices
4Tissue
At 4Tissue, we’re pioneering the future of regenerative medicine with innovative hydrogel solutions that support natural tissue restoration. We are an innovation-led research and clinical development organization. Our mission is to redefine the boundaries of tissue reconstruction, regeneration, and anti-aging, utilizing innovative biocompatible and bioresorbable polymers platform The first product, a bioresorbable injectable hydrogel, is focused on a better cell survival and the full regeneration of adipose tissue for breast reconstruction and augmentation applications.